Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop)
{{output}}
Background and purpose: Cladribine tablets, a purine analogue antimetabolite, offer a unique treatment regimen, involving short courses at the start of the first and second year, with no further treatment needed in years 3 and 4.... ...
